On Tuesday, Moderna announced that children have begun to receive vaccinations in its Phase 2/3 pediatric Covid-19 vaccine trial.
The “KidCOVE study” is a clinical trial that will include around 6,750 children in Canada and the United States. Children involved in the trial will be between 6 months and 11 years old.
.png)
.png)
